Clinical Trials
2 trialsNCT00238329 2013-04-08
PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT00072345 2013-01-18
Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed